MediRama

Contact us LinkedIn

Resources

임상시험, 규제 전략, 혁신 항암제에 대한 컨퍼런스 및 웨비나 소식을 전해드립니다.

전체 7건

View More

[MediRama EDGE] Vyloy for Gastric Cancer

  • 2024.11.28
View More

[MediRama EDGE] NDA story of Rytelo(imetelstat)

  • 2024.10.24
View More

[MediRama EDGE] Tecelra BLA

  • 2024.09.26
View More

[MediRama EDGE] Belzutifan for RCC

  • 2024.08.29
View More

[MediRama EDGE] Imdelltra BLA story

  • 2024.07.25
View More

Significance of data quality getting regular approval from accelerated approval : Lumakras Case

  • 2024.04.25
View More

[MediRama EDGE] Approval history of Amtagvi(Lifileucel)_First TIL therapy

  • 2024.03.28